1. Hercend T, Schmidt RE. Characteristics and uses of natural killer cells. Immunol Today 1988; 9: 291–3.
2. Harris DT, Jaso-Friedmann L, Devlin RB, Koren HS, Evans DL. Identification of human natural killer cell target cell antigen with monoclonal antibodies. J Immunol 1989; 143: 727–35.
3. Aramburu J, Balboa MA, Ramirez A, Silva A, Acevedo A, Sanchez-Madrid F, De Landazuri MO, Lopez-Botet M. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta T lymphocytes. J Immunol 1990; 144: 3238–47.
4. Hercend T, Farace F, Baume D, Charpentier F, Droz JP, Triebel F, Escudier B. Immunotherapy with lymphokineactivated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinoma. J Biol Res Mod 1990; 9: 546–55.
5. Pflueger E, Mueller EA, Anderer FA. Preservation of cytotoxic function during multi-cycle immunomagnetic cell separations of human NK cells using a new type of magnetic bead. J Immunol Methods 1990; 129: 165–73.